ArticleDrug design, development and therapy2017

Inhibition of lymphangiogenesis in vitro and in vivo by the multikinase inhibitor nintedanib.

Tong Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.